StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.89−0.05 (-2.58%)

Close on Nov 16, 2026Market cap $18.22MP/E –Yield –

Edesa Biotech gross margin

Gross margin is gross profit as a percentage of revenue.

Edesa Biotech's gross margin for the twelve months ending Jun 30, 2021 was -362.8%. For fiscal 2020 it was 94.6%, against 37.1% the year before. The highest annual figure on record is 94.6% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2020Sep 30, 202094.6%+57.6
FY2018Sep 30, 201837.1%+46.6
FY2017Sep 30, 2017-9.5%−45.2
FY2016Sep 30, 201635.6%+61.7
FY2014Aug 31, 2014-26.1%−115.6
FY2013Aug 31, 201389.5%+138.5
FY2012Aug 31, 2012-49.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2020CQ3 2020Sep 30, 2020-362.8%−462.8
Q3 FY2020CQ2 2020Jun 30, 202098.7%+34.2
Q2 FY2020CQ1 2020Mar 31, 202090.9%+93.4
Q1 FY2020CQ4 2019Dec 31, 201996.5%+10.2
Q3 FY2019CQ2 2019Jun 30, 2019100.0%+780.5
Q4 FY2018CQ3 2018Sep 30, 201864.5%+342.2
Q2 FY2018CQ1 2018Mar 31, 2018-2.5%+10.9
Q1 FY2018CQ4 2017Dec 31, 201786.3%+41.7
Q4 FY2017CQ3 2017Sep 30, 2017-680.5%−737.9
Q3 FY2017CQ2 2017Jun 30, 2017-277.7%–
Q2 FY2017CQ1 2017Mar 31, 2017-13.4%–
Q1 FY2017CQ4 2016Dec 31, 201644.6%–
Q4 FY2016CQ3 2016Sep 30, 201657.4%–

More Edesa Biotech figures

See a number that looks wrong?